14 advisor opinions Base Subscription Required
Oklo AI Forecast Summary
Unlock the rating distributions, return ranges and advisor comparison with a Base subscription.
Checking your access...
Browse Free Assets1 Year Ratings & Returns ()
Ratings: 2 Neutral 12 Strong Buy
Returns range: from +3.8% to +89.3%
5 Year Ratings & Returns ()
Ratings: 1 Sell All 1 Partial Sell 3 Neutral 9 Strong Buy
Returns range: from -54.9% to +425.0%
Calculated from End of Date $25.09
What do advisors disagree on
The decisive disagreement centers on whether Oklo's massive customer pipeline translates into per-share equity value or merely funds a dilutive construction treadmill. Optimistic analyses view non-binding letters of intent and Department of Energy pilot approvals as proof of an unassailable commercial moat that will generate utility-scale EBITDA. Contrarian reports prove that because Oklo operates as an owner-operator rather than an IP licensor, physical fleet fabrication requires billions in capital, ensuring continuous ATM dilution under high benchmark interest rates. This dispute will be resolved when commercial power off-take tariffs and binding project financing structures are officially disclosed.
Compare all 14 opinions1 Year & 5 Year ratings, targets & returns · Sorted by 5 Year price return
| Advisor | Model | Research | 1 Year | 5 Year | Full Report | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Target date | Rating | Price target | Price return | Target date | Rating | Price target | Price return | ||||
| J.P. Morgan AI The Titan Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $47.50 | +89.3% | $131.72 | +425.0% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $44.26 | +76.4% | $94.91 | +278.3% | Full report | ||||
| Niccolo Machiavelli AI The Insider Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $35.31 | +40.7% | $90.72 | +261.6% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $41.06 | +63.6% | $85.73 | +241.7% | Full report | ||||
| Sherlock Holmes AI The Whistleblower Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $35.63 | +42.0% | $71.85 | +186.4% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $33.13 | +32.0% | $67.13 | +167.6% | Full report | ||||
| Universal Investor AI The Polymath Framework | Claude Opus 5 | Researcher Mode with Web Search Used | $37.89 | +51.0% | $62.51 | +149.1% | Full report | ||||
| Ray Dalio AI The Strategist Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $37.79 | +50.6% | $56.50 | +125.2% | Full report | ||||
| Elon Musk AI The Visionary Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $29.30 | +16.8% | $47.90 | +90.9% | Full report | ||||
| Universal Investor AI The Polymath Framework | GPT-6 Astra | Researcher Mode with Web Search Used | $30.46 | +21.4% | $34.56 | +37.8% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $30.36 | +21.0% | $31.21 | +24.4% | Full report | ||||
| Michael Burry AI The Vulture Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $26.04 | +3.8% | $30.49 | +21.5% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $31.23 | +24.5% | $23.58 | -6.0% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $26.40 | +5.2% | $11.30 | -54.9% | Full report | ||||
Prices, dates & return assumptions
1 Year and 5 Year identify the original published checkpoints. Current returns compare the dated close with each fixed target over its remaining horizon. Original quarterly tables use the publication-time anchor. Targets and observed prices share a split-adjusted basis.
Ratings use the shared volatility-adjusted calculation.
Ranges and rating distributions use matching currencies, price bases and target dates. Missing or expired checkpoints are excluded; targets are never extrapolated. Shared frameworks and models can produce correlated opinions.
Oklo Stock Analysis & Forecast — Universal Investor The Polymath Framework on Gemini 3.8 Flash Model
Universal Investor AI · The Polymath Framework
5 Year Rating
5 Year Price Return
+278.3%
Framework Description & Key Record Dates
Investment Framework
The Polymath Framework: Eight-Lens Investment Analysis Framework
Analysis Framework Description: Select the lenses with the greatest explanatory power, resolve their disagreements across horizons, and connect the evidence to a consistent thesis, scenario path, and verdict.
- Ownership and value: examine economic rights, competitive advantage, capital allocation, and the price paid.
- Regimes and constraints: connect credit, liquidity, policy, demand, and physical bottlenecks to the asset.
- Innovation and adaptation: test adoption economics, AI and robotics exposure, substitution, and value capture.
- Forensics and incentives: reconcile accounting, cash conversion, dilution, governance, and missing evidence.
- Expectations and reflexivity: distinguish changes in fundamentals from changes in narratives and valuation.
- Probabilities and resilience: use base rates, competing scenarios, catalysts, and the capacity to survive the wait.
- Power and the rules of the game: assess political interests, regulatory influence, protection, and dependency.
- Industry structure and consolidation: identify pricing power, chokepoints, alliances, and the economics of integration.
- Model Producer:
- Model Version:
- Gemini 3.8 Flash
- Mode Used:
- Researcher
- Input Data:
- Input records not available
- Forecast Target Date:
- Latest Known Price Date for Return Estimate Refresh:
- Forecast Published On:
- Forecast Generated On:
- Model knowledge cutoff:
- Supplied Context Data, Prices & Events Cutoff:
- Not recorded
Return calculation details
Current returns use the observed price and remaining time to the fixed published target. The quarterly table retains the original forecast anchor.
Full advisor report Chart, analysis, and sources
Oklo: Historical Prices & Published Forecast
Analyzed by The Polymath Framework using the Gemini 3.8 Flash model
- Observed price
- Published advisor forecast
Oklo: Quarterly Price Forecasts & Scenarios
Analyzed by The Polymath Framework using the Gemini 3.8 Flash model
Price targets, price returns and complete scenario reasoning
Forecast prices in USD. Price returns are cumulative from the original forecast anchor dated 2026-09-18; they exclude dividends. Swipe horizontally to read every column.
| Quarter | Forecast | Price return | Scenario |
|---|---|---|---|
| $39.9 | +5.0% | Autumn DOE preliminary safety documentation advances at Aurora-INL alongside initial procurement contracts. Despite broader tech capex scrutiny and persistent federal interest rates, tangible site preparation progress sustains buying interest, producing modest quarterly share price appreciation. | |
| $42.7 | +12.3% | First commercial radioisotope shipments commence from the Idaho Radiochemistry Laboratory, demonstrating audited initial revenues. This milestone validates management execution and diversifies cash generation away from exclusive power dependency, attracting institutional fundamental growth capital. | |
| $41.0 | +7.9% | Accelerated capital expenditures and active utilization of at-the-market equity facilities introduce temporary per-share dilution drag. High Treasury yields keep long-duration valuation multiples constrained, prompting profit-taking following the prior quarter's commercialization rally. | |
| $44.3 | +16.5% | Centrus Energy delivers initial domestic HALEU fuel allocations, meaningfully de-risking the critical fuel supply chain. Simultaneously, formalization of binding hyperscaler power purchase terms reinforces long-term revenue visibility, prompting strong upward repricing across advanced energy equities. | |
| $46.9 | +23.5% | Aurora-INL mechanical and civil construction milestones reach advanced completion ahead of 2028 testing targets. Radioisotope revenue expansion further reduces net operational cash burn, boosting investor conviction in Oklo's integrated fast-fission technology platform. | |
| $44.1 | +16.1% | Intensive pre-criticality safety reviews at Idaho National Laboratory introduce routine testing pauses, prompting speculative capital outflows. Increased research overhead and elevated pre-commissioning expenses widen quarterly net losses, temporarily dampening market sentiment. | |
| $50.3 | +32.3% | Aurora powerhouse achieves initial operational criticality under the Department of Energy Reactor Pilot Program. This landmark technical breakthrough shatters commercial skepticism regarding fast-spectrum microreactor viability, igniting aggressive momentum-driven institutional accumulation. | |
| $54.8 | +44.2% | Grid synchronization and successful low-power operational testing at INL trigger the submission of the commercial NRC conversion application. Hyperscale off-takers expand commercial campus commitments, sustaining robust upward valuation momentum. | |
| $52.1 | +37.0% | Year-end tax loss harvesting and a secondary equity financing round to fund commercial Aurora-Ohio site development dilute per-share metrics. Investors digest rapid price appreciation as operational focus pivots from testing to full commercial deployment. | |
| $56.2 | +48.0% | NRC formal acceptance of the Aurora-Ohio combined license application establishes clear regulatory visibility for Oklo's commercial fleet rollout. Medical isotope cash flows expand steadily, mitigating corporate burn and strengthening fundamental investor backing. | |
| $62.4 | +64.2% | Groundbreaking on the multi-unit Ohio data center campus alongside Kiewit begins, accompanied by substantial non-dilutive customer milestone prepayments. This tangible capital injection significantly enhances liquidity and accelerates project return timelines. | |
| $64.9 | +70.8% | Macroeconomic easing and lower interest rates lower discounting hurdles for capital-intensive infrastructure assets. Stable operational performance at the Idaho pilot facility validates long-term reliability metrics, maintaining steady upward price pressure. | |
| $63.0 | +65.7% | Supply chain delays for specialized sodium coolant piping components cause modest construction schedule revisions in Ohio. The temporary pause introduces minor headline volatility, leading to mild profit-taking into the fiscal year close. | |
| $67.4 | +77.3% | Component supply bottlenecks resolve as domestic specialized manufacturing capacity scales. Oklo signs additional preliminary letters of intent with industrial off-takers, expanding its forward pipeline and reinforcing long-term market dominance. | |
| $75.5 | +98.6% | Commercial operation at the first unit of the Aurora-Ohio complex commences, delivering primary baseload electricity to hyperscale data center customers. First commercial power revenue recognition marks a transformative milestone, sparking powerful institutional rerating. | |
| $81.5 | +114.5% | Full-scale operational cash flow generation from commercial power sales proves unit economic viability and high gross margins. Analysts rapidly upgrade forward earnings projections, driving strong equity demand as revenue visibility solidifies. | |
| $78.2 | +105.9% | Seasonal routine maintenance and scheduled refueling outages produce a temporary pause in revenue expansion. Broad market consolidation and rotation out of capital-goods outperformers trim recent equity gains. | |
| $82.9 | +118.2% | Subsequent reactor units enter commercial operation at the Ohio campus, compounding electricity sales volume. High fleet availability metrics validate the fast-fission design, enhancing long-term operational cash-flow durability and investor confidence. | |
| $90.4 | +137.9% | Announcement of a multi-reactor expansion agreement across western industrial hubs significantly expands long-term pipeline capacity. Oklo demonstrates substantial operating leverage, expanding operating income and driving broad-based institutional equity accumulation. | |
| $94.9 | +149.8% | Consolidated five-year commercial execution solidifies Oklo as a premier independent clean power producer. Robust combined revenues from commercial baseload electricity and high-margin radioisotope production underpin an enduring, premium public market valuation. |
Show remaining 18 quartersShow first 2 quarters only
All 20 quarters are displayed in the table above.
Oklo: Investment Thesis Base Case
Analyzed by The Polymath Framework using the Gemini 3.8 Flash modelThe base case rests on Oklo successfully leveraging its Department of Energy pilot authorization to achieve initial operational power by 2028, supported by intermediate cash flows from medical radioisotope production. Massive hyperscaler power deficits ensure complete off-take monetization at premium electricity rates, offsetting elevated first-of-a-kind engineering expenses. While ongoing capital expenditures and equity offerings dilute per-share gains, Oklo’s fortified cash reserves eliminate solvency risk. Over the five-year horizon, Oklo evolves from a speculative development-stage venture into a commercially validated, high-margin clean energy producer commanding a premium infrastructure valuation.
- Cash reserves exceeding two billion dollars adequately fund projected cumulative capital outlays through commercial startup in 2028.
- Commercial power purchase agreement conversion supports an enterprise value multiple exceeding thirty times projected operational cash generation.
- Terminal equity value reflects approximately one hundred megawatts of operational capacity commanding twelve billion dollars in capitalized worth.
Oklo: Scenarios & Signals
Analyzed by The Polymath Framework using the Gemini 3.8 Flash modelBull Case
Flawless execution at Aurora-INL activates rapid NRC commercial licensing reciprocity, unlocking accelerated multi-unit power deployments across Ohio and Texas by 2029. Hyperscale partners inject billions in direct project equity co-investments, eliminating equity dilution while HALEU enrichment capacity scales ahead of schedule. As commercial isotope sales deliver unexpected high-margin cash flows, operating leverage compounds rapidly, driving the quoted equity price toward triple-digit territory as Oklo solidifies its monopoly in turnkey advanced nuclear infrastructure.
Bear Case
Severe engineering setbacks and sodium handling hazards at the Idaho pilot reactor trigger indefinite Department of Energy stop-work orders by late 2027. Compounding regulatory paralysis, critical HALEU fuel allocations fail to materialize, stranding civil assets while annual operating cash burns exceed two hundred million dollars. Hyperscalers cancel preliminary off-take agreements in favor of conventional gas turbines, forcing massive asset write-downs, aggressive dilutive recapitalizations, and an enduring collapse in the equity multiple toward tangible book value.
Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime: High
Greed and Fear Index: +22 / 100 (Greed)
Cycle Position: Stabilization
The reset is mostly complete and price drifts toward fair value.
What does Media Tell? (Crowd Consensus)
Consensus views Oklo as a high-beta speculative proxy on artificial intelligence power demand, treating Sam Altman’s sponsorship and hyperscaler memorandums of understanding as guaranteed future cash flows. Sell-side research anchors on multi-gigawatt pipeline headlines while dismissing commercial licensing hurdles and HALEU supply constraints. Positioning reflects uncritical enthusiasm, pricing rapid reactor deployment as settled fact despite zero commercial power generation today.
What Crowds Get Wrong? (Alpha/Value Gap)
The crowd overestimates the near-term velocity of Oklo’s commercial power transition while severely underestimating the strategic economic value of its vertically integrated fuel and isotope infrastructure. Consensus fixates on distant power purchase agreements, creating vulnerability to inevitable nuclear construction delays. However, forensic analysis reveals that early high-margin isotope monetization and the Department of Energy pilot pathway provide tangible operational milestones the market overlooks. Repricing occurs as investors discover that execution speed in fuel and regulatory precedent, rather than raw gigawatt pipeline announcements, dictates terminal equity value.
When will Value Gap Repricing Happen? (Repricing Catalyst)
The primary convergence catalyst is the operational commissioning and initial commercial isotope revenue recognition from the Idaho Radiochemistry Laboratory in early 2027. Demonstrating audited non-dilutive revenues and verifiable facility throughput will force analysts to transition from speculative pipeline heuristics to fundamental discounted cash-flow models, establishing an initial valuation floor.
How is Asset Influenced by Macro Regime?
The macroeconomic regime presents a tangible headwind. Elevated policy rates near 4.00% and high Treasury yields compress long-duration growth multiples and raise project debt hurdles. However, persistent energy supply disruptions and surging industrial electricity rates provide powerful countervailing microeconomic support, preserving customer willingness to pay high contract prices for dependable baseload nuclear power.
Oklo: Positive & Negative Factors, Risks & Opportunities
Analyzed by The Polymath Framework using the Gemini 3.8 Flash modelBase-Case Forces
Top Drivers / Tailwinds
Base-case positive forces
Structural or operating forces that support this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Hyperscaler Power Starvation Secures OFF | Competitive Positioning | +38% | +55% | Evidence shows data centers face severe grid interconnection delays of up to seven years, driving hyperscalers directly toward behind-the-meter nuclear developers. Oklo’s build-own-operate model directly captures long-term power purchase agreements at premium pricing, demonstrated by multi-hundred-megawatt commitments. This customer desperation suggests durable pricing power across multi-decade contracts, insulating prospective revenues from wholesale merchant electricity volatility and anchoring long-term commercial enterprise valuation. |
| DUAL Track Regulatory Pathway Expedites | Regulatory | +28% | +35% | Regulatory forensics reveal that bypassing traditional NRC bottlenecks via the Department of Energy’s Reactor Pilot Program significantly derisks Oklo’s execution timeline. Approval of the Nuclear Safety Design Agreement at Idaho National Laboratory, alongside NRC Principal Design Criteria approval, corroborates an accelerating institutional posture. This regulatory tailwind reduces pre-construction development lead times by years, lowering cumulative pre-revenue overhead and expanding the terminal multiple investors will pay. |
| Multi YEAR Liquidity Buffer Shields EXEC | Capital Allocation | +22% | +15% | Management’s aggressive utilization of at-the-market equity facilities amassed over two billion dollars in liquid reserves by mid-2026. This financial cushion eliminates near-term insolvency threats and funds accelerated procurement for the Aurora-INL reactor without requiring punitive high-yield debt. The absence of immediate financing distress allows systematic capital deployment through capital-intensive construction phases, insulating operations from cyclical debt market freezes and sustaining investor confidence. |
| Medical Radioisotope Production Provides | Innovation And Product | +18% | +40% | Achieving first criticality at the Groves test reactor in August 2026 validates Oklo’s commercial radioisotope timeline ahead of primary reactor deployments. Commercializing medical isotopes via the Idaho Radiochemistry Laboratory establishes high-margin cash generation starting in 2027. This revenue stream partially offsets corporate burn before full-scale powerhouses commission, demonstrating functional manufacturing execution and providing early proof of commercial viability that supports near-term valuation. |
Top Frictions / Headwinds
Base-case negative forces
Expected frictions that can slow, cap, or damage this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Domestic Haleu Enrichment Chokepoints TH | Sector And Industry | -24% | -35% | Investigation of the nuclear fuel cycle reveals severe domestic shortages of High-Assay Low-Enriched Uranium following Russian import restrictions. Commercial supply remains concentrated in limited enrichment tranches, which creates acute procurement bottlenecks for advanced fast-fission reactors. This physical constraint risks delaying multi-unit Aurora rollouts beyond initial demonstration sites, depressing multi-year fleet revenue projections and compelling Oklo to absorb premium feedstock prices that squeeze future operating margins. |
| First OF A KIND Construction COST Premiu | Operational Efficiency | -20% | -30% | Historical base rates across advanced nuclear projects confirm that first-of-a-kind builds routinely encounter procurement inflation and engineering revisions. Oklo raising 2026 capital expenditure guidance to five hundred million dollars corroborates emerging cost escalation at Aurora-INL. This capex expansion accelerates cash consumption, which leads to lower return on invested capital across initial units and compresses near-term cash-flow yield expectations relative to standardized light-water competitors. |
| Equity Dilution Erodes PER Share Economi | Capital Allocation | -18% | -10% | While at-the-market share issuances successfully fortified the balance sheet, they simultaneously expanded the share count to one hundred seventy-six million shares. Ongoing reliance on equity distribution programs to fund massive reactor capex transfers substantial enterprise value away from existing shareholders. Continued share issuance diminishes per-share cash flow claims, which caps the quoted stock price’s upside even as gross commercial megawatts under pipeline expand. |
| Persistent HIGH Interest Rates Penalize | Macroeconomic And Macrofinancial | -15% | -5.0% | The Federal Reserve raising policy rates to 3.75%-4.00% and ten-year Treasury yields hovering near five percent severely penalize pre-profit growth assets. Nuclear developers whose primary cash flows lie five to ten years in the future suffer disproportionate valuation compression under elevated discount rates. Tighter macrofinancial conditions increase the hurdle rate for capital allocation, depressing the price-to-book and enterprise-value multiples institutional allocators will pay. |
Risks & Opportunities
Top Risks / Downside Scenarios
Lower-probability downside scenarios outside the base-case forecast.
Unlock the risk analysis
Sign in with eligible access to read risks, opportunities and the remaining advisor reports.